MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Decline in functionality according to WHODAS 2.0 associated with disease progression in people with Parkinson’s disease

N. Pereira, K. Nóbrega, I. Nascimento, L. Matos, L. Aranha, C. de Paula, C. Santana, R. Bocicovar, G. Campos, F. Fidelis, G. Dos Santos, I. Barone, V. Ponciano, M. Piemonte (São Paulo, Brazil)

Meeting: 2024 International Congress

Abstract Number: 1840

Keywords: Multidisciplinary Approach, Parkinson’s, Scales

Category: Phenomenology and Clinical Assessment of Movement Disorders

Objective: To investigate the decline in functionality according to WHODAS-2.0 from early to intermediate stages of PD.

Background: Parkinson’s disease (PD) is an incurable and chronic condition that causes both motor and non-motor alterations. These alterations progressively increase the level of disability and decrease the functionality of the affected individual. To provide a standardized method for measuring the impact of any health condition in terms of functionality, the WHO has developed the Disability Assessment Schedule (WHODAS-2.0), based on the ICF-framework.

Method: This cross-sectional study was included 350 individuals with idiopathic PD (189 women and 161 men) with a mean age of 58.10 ±11.04 years, between stages I-III in the H&Y scale. The mean time since diagnosis was 7.09 years (±5.53) . The data collection were involved the application of the functionality questionnaire (WHOODAS-2.0), the assessment of motor and non-motor alterations (MDS-UPDRS I and II) and clinical characterization data. All the tests were completed remotely by a specialized physiotherapist in a single call by telephone. We used a six Kruskal-Wallis ANOVA, one for each WHODAS-2.0 domains, to compare the H&Y-stages (I-II-III). Additionally, we used the Pearson test to test the correlation between WHODAS-2.0 total scores and MDS-UPDRS I and II.

Results: The KW-ANOVA analysis, adjusted for multiple comparisons, revealed that the H&Y stages had a significant effect on both the total score and all domains of the WHODAS 2.0. In pair-to-pair comparisons, statistically significant differences (p<.001) were observed between all three H&Y stages for the total score and most WHODAS-2.0 domains. However, for the Cognition and Activities related to the job domains, there was a significant difference only between stage I and III H&Y (p<.01). Additionally, there was a statistically significant correlation between the total scores of WHODAS 2.0 with UPDRS I (r=0.67) and UPDRS II (r=0.66).

Conclusion: As PD progresses, all aspects of functionality gradually decline since the early stages of the disease. However, only cognition and work activities are impaired at a later stage. To minimize the decline in functionality, comprehensive care should be provided by an interprofessional team from the time of PD diagnosis.

To cite this abstract in AMA style:

N. Pereira, K. Nóbrega, I. Nascimento, L. Matos, L. Aranha, C. de Paula, C. Santana, R. Bocicovar, G. Campos, F. Fidelis, G. Dos Santos, I. Barone, V. Ponciano, M. Piemonte. Decline in functionality according to WHODAS 2.0 associated with disease progression in people with Parkinson’s disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/decline-in-functionality-according-to-whodas-2-0-associated-with-disease-progression-in-people-with-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/decline-in-functionality-according-to-whodas-2-0-associated-with-disease-progression-in-people-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley